CF PHARMTECH (02652) spent 382,900 Hong Kong dollars to repurchase 11,000 shares on January 26th.

20:03 26/01/2026

Changfeng Pharmaceutical (02652) announced that on January 26, 2026, the company repurchased 11,000 shares at a total cost of 382,900 Hong Kong dollars, with a repurchase price of 34.30-35.48 Hong Kong dollars per share.

CF PHARMTECH (02652) announces that on January 26, 2026, the company repurchased 11,000 shares for a total of 382,900 Hong Kong dollars, at a repurchase price of 34.30-35.48 Hong Kong dollars per share.

SHENGHUI CLEAN (02521): Dong Jiangang appointed as executive director.

Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.

CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.

SHENGHUI CLEAN (02521): Dong Jiangang appointed as executive director.

Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.

CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.